BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36740095)

  • 1. Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5.
    Moermans C; Brion C; Bock G; Graff S; Gerday S; Nekoee H; Poulet C; Bricmont N; Henket M; Paulus V; Guissard F; Louis R; Schleich F
    Chest; 2023 Jun; 163(6):1368-1379. PubMed ID: 36740095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum autoantibodies in patients with severe eosinophilic asthma.
    Mukherjee M; Bulir DC; Radford K; Kjarsgaard M; Huang CM; Jacobsen EA; Ochkur SI; Catuneanu A; Lamothe-Kipnes H; Mahony J; Lee JJ; Lacy P; Nair PK
    J Allergy Clin Immunol; 2018 Apr; 141(4):1269-1279. PubMed ID: 28751233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum.
    Yamada H; Yamaguchi M; Yamamoto K; Nakajima T; Hirai K; Morita Y; Sano Y; Yamada H
    Allergy; 2000 Apr; 55(4):392-7. PubMed ID: 10782526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.
    Hastie AT; Moore WC; Li H; Rector BM; Ortega VE; Pascual RM; Peters SP; Meyers DA; Bleecker ER;
    J Allergy Clin Immunol; 2013 Jul; 132(1):72-80. PubMed ID: 23706399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
    Bjerregaard A; Laing IA; Poulsen N; Backer V; Sverrild A; Fally M; Khoo SK; Barrett L; Baltic S; Thompson PJ; Chidlow G; Sikazwe C; Smith DW; Bochkov YA; Le Souëf P; Porsbjerg C
    Respir Med; 2017 Feb; 123():34-41. PubMed ID: 28137494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study.
    Kallieri M; Papaioannou AI; Papathanasiou E; Ntontsi P; Papiris S; Loukides S
    Postgrad Med; 2017 Aug; 129(6):598-604. PubMed ID: 28427296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J; Jiang F; Nayeri F; Zetterström O
    Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.
    Mukherjee M; Aleman Paramo F; Kjarsgaard M; Salter B; Nair G; LaVigne N; Radford K; Sehmi R; Nair P
    Am J Respir Crit Care Med; 2018 Jan; 197(1):38-46. PubMed ID: 28915080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma.
    Kim CK; Choi J; Callaway Z; Iijima K; Volcheck G; Kita H
    Respir Med; 2010 Oct; 104(10):1436-43. PubMed ID: 20709516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.
    Kim CK; Kita H; Callaway Z; Kim HB; Choi J; Fujisawa T; Shin BM; Koh YY
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e697-704. PubMed ID: 20444156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.
    Smith SG; Gugilla A; Mukherjee M; Merim K; Irshad A; Tang W; Kinoshita T; Watson B; Oliveria JP; Comeau M; O'Byrne PM; Gauvreau GM; Sehmi R
    J Allergy Clin Immunol; 2015 Jun; 135(6):1594-602. PubMed ID: 25656998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
    Jackson DJ; Humbert M; Hirsch I; Newbold P; Garcia Gil E
    Adv Ther; 2020 Feb; 37(2):718-729. PubMed ID: 31836949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma.
    Tang M; Charbit AR; Johansson MW; Jarjour NN; Denlinger LC; Raymond WW; Peters MC; Dunican EM; Castro M; Sumino K; Erzurum SC; Comhair SA; Moore WC; Levy BD; Israel E; Phipatanakul W; Phillips BR; Mauger DT; Bleecker ER; Wenzel SE; Fajt ML; Woodruff PG; Hastie AT; Fahy JV;
    J Allergy Clin Immunol; 2024 Apr; ():. PubMed ID: 38663815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma.
    Ko HK; Cheng SL; Lin CH; Lin SH; Hsiao YH; Su KC; Yu CJ; Wang HC; Sheu CC; Chiu KC; Perng DW
    Sci Rep; 2021 Apr; 11(1):8425. PubMed ID: 33875671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.
    Nair P; Ochkur SI; Protheroe C; Radford K; Efthimiadis A; Lee NA; Lee JJ
    Allergy; 2013 Sep; 68(9):1177-84. PubMed ID: 23931643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic markers of allergic bronchopulmonary aspergillosis in patients with severe asthma.
    Kozlova Y; Frolova E; Uchevatkina A; Filippova L; Aak O; Burygina E; Taraskina A; Vasilyeva N; Klimko N
    Mycoses; 2020 Jun; 63(6):596-603. PubMed ID: 32246509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking attenuates the age-related decrease in IgE levels and maintains eosinophilic inflammation.
    Nagasaki T; Matsumoto H; Nakaji H; Niimi A; Ito I; Oguma T; Muro S; Inoue H; Iwata T; Tajiri T; Kanemitsu Y; Mishima M
    Clin Exp Allergy; 2013 Jun; 43(6):608-15. PubMed ID: 23711122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.
    Kalinauskaite-Zukauske V; Januskevicius A; Janulaityte I; Miliauskas S; Malakauskas K
    BMC Pulm Med; 2019 Aug; 19(1):158. PubMed ID: 31438916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent.
    Salter BM; Oliveria JP; Nusca G; Smith SG; Watson RM; Comeau M; Sehmi R; Gauvreau GM
    J Allergy Clin Immunol; 2015 Dec; 136(6):1636-1644. PubMed ID: 25962901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.